Formulation and Evaluation Tolbutamide Liposomes for a Sustained Drug Delivery System

Authors

  • Devendra Prajapati Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
  • Dr. Arindam Chatterjee Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
  • Dr. Mayank Bansal Department of Pharmaceutics, Jaipur College of Pharmacy, Jaipur, Rajasthan, India
  • Saurabh Pandey Executive Officer, Agog Pharma Ltd

DOI:

https://doi.org/10.32553/jbpr.v11i6.945

Keywords:

Sustained drug delivery system, physical dispersion method, ether injection method, soya lecithin, stability studies

Abstract

Novel Drug Delivery system (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. Applications of liposomes in medicine and pharmacology can be divided into diagnostic and therapeutic applications of liposomes containing various markers or drugs. The aim of the study was to formulate and evaluate Tolbutamide liposomes for a sustained drug delivery system. The tolbutamide was prepared as a liposomal drug delivery system by using two different techniques such as physical dispersion method and ether injection method. The morphological characters of prepared liposomes were determined with the help of optical microscope. The results of the particle size showed, when the concentration of soya lecithin was increased the size of the particle was reduced. The in vitro release showed that as the concentration of soya lecithin was increased the release rate of drug was retarded. Among the two methods ether injection method showed prolonged action when compared to physical dispersion method. The stability studies for all the formulations were performed by keeping the formulations at two different temperatures 4ºC±2ºC and 25ºC±2ºC for a period of 30 days. There was no change in morphological characters at 4ºC±2ºC, but there was a slight reduced in particles size at 25ºC±2ºC. The percentage drug entrapment was reduced in all the formulations at both the conditions.

Downloads

Published

2022-12-02

How to Cite

Prajapati, D. ., Chatterjee, D. A. ., Bansal, D. M. ., & Pandey, S. (2022). Formulation and Evaluation Tolbutamide Liposomes for a Sustained Drug Delivery System. Journal of Biomedical and Pharmaceutical Research, 11(6). https://doi.org/10.32553/jbpr.v11i6.945

Issue

Section

Articles

Most read articles by the same author(s)